{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:49:32Z","timestamp":1784562572520,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.amjcard.2017.03.016","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T04:02:05Z","timestamp":1490760125000},"page":"1917-1923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study)"],"prefix":"10.1016","volume":"119","author":[{"given":"Konstanze","family":"Ertelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin J.","family":"Brener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McAndrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.03.016_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.03.016_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0735-1097(97)00118-6","article-title":"Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded coronary Arteries","volume":"30","author":"Mak","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.03.016_bib3","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa0810116","article-title":"Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction","volume":"360","author":"Stone","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.03.016_bib4","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2017.03.016_bib5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The Thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. TIMI study group","volume":"312","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.03.016_bib6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.03.016_bib7","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.03.016_bib8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.amjcard.2011.11.046","article-title":"Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI)","volume":"109","author":"Brener","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.03.016_bib9","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jcmg.2012.01.008","article-title":"Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes","volume":"5","author":"Marso","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2017.03.016_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.amjcard.2010.04.015","article-title":"Comparison of\u00a0platelet reactivity and periprocedural outcomes in patients with\u00a0versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention","volume":"106","author":"Mangiacapra","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.03.016_bib11","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1161\/01.CIR.0000142047.28024.F2","article-title":"Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan in Acute myocardial iNfarcTion (VALIANT) trial","volume":"110","author":"Aguilar","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.03.016_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/MCA.0000000000000090","article-title":"Short-term and long-term adverse cardiovascular events across the glycaemic spectrum in patients with acute coronary syndrome: the Gulf Registry of Acute Coronary Events-2","volume":"25","author":"Alfaleh","year":"2014","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.amjcard.2017.03.016_bib13","doi-asserted-by":"crossref","first-page":"A17910","DOI":"10.1161\/circ.130.suppl_2.17910","article-title":"Abstract 17910: patients with newly diagnosed diabetes have comparable long term mortality with known diabetics after ST segment elevation myocardial infarction","volume":"130","author":"Aggarwal","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.03.016_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCULATIONAHA.110.985911","article-title":"Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention","volume":"124","author":"Timmer","year":"2011","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917303399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917303399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T10:23:03Z","timestamp":1655288583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917303399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0002914917303399"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.03.016","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}